The following trends were observed for angiotensin receptor level with regard to type of prostate cancer cell line: AT1: PC3 > LNCaP > DU-145; AT2: LNCaP > DU-145 > PC3; AT1–7/MAS: DU-145 > LNCaP > PC3; AT4/IRAP: PC3 > LNCaP > DU-145. This evidence concerns the gene AGTR2 and prostate cancer.